Personal Injury
-
February 27, 2025
Field Law welcomes five partners, two counsel
Lee Carter, Carolyn Paterson, Pat Robinson and Matt Vernon, based in Calgary, and Paul Kolida, in Edmonton, have been promoted to the position of partners while Don Blackett and Karen Wiwchar named counsel at Field Law., according to an announcement on the firm’s website.
-
February 27, 2025
Settlement versus trial: Making an informed decision
Personal injury claims arise when an individual suffers harm due to another party’s negligence, recklessness or intentional misconduct. These claims often involve physical, emotional and financial distress for the injured party.
-
February 26, 2025
Hosel rockets: When sport becomes tort | Michael Cochrane
The United Kingdom’s St. Augustine’s Links describes itself as Kent’s most welcoming golf course. I’m not sure Mr. Castle felt that way as he drove his taxi alongside the 13th hole in 1922, especially when an errant golf ball smashed through his windshield, blinding him in one eye. Was the ball one of the then popular $12 a dozen “C” Colonel’s advertised as “leaves the club with a click and a delightful feeling”? We know not. What we do know is that, while the course felt bad, they explained those types of errant shots happened all the time, especially — ahem — on the 13th hole. Castle sued.
-
February 26, 2025
Federal Court strikes $100M class action against Canada over its handling of COVID-19 pandemic
The Federal Court has dismissed a proposed $100-million class action lawsuit against the federal government over its handling of the COVID-19 pandemic.
-
February 26, 2025
Ontario Trial Lawyers’ Association calls for key auto insurance changes amid election clamour
In the run-up to Ontario’s Feb. 27 election this week, the organization that represents more than 1,300 legal professionals in the personal injury sector has been campaigning to raise awareness about issues with the province’s auto insurance system that it argues are unfair to accident victims and the personal injury bar.
-
February 26, 2025
SCC halts use of its ‘X’ account ‘for now,’ citing ‘strategic priorities and resource allocation’
In a move that has sparked controversy in Canada and beyond, the Supreme Court of Canada tells Law360 Canada that “for now” it will no longer use its official account on X, the social media platform owned by Elon Musk, a high-profile billionaire associate of U.S. President Donald Trump.
-
February 26, 2025
Women & 2SLGBTQI+ applicants came out ahead as ‘highly recommended’ for federal benches in 2023-2024
Asserting his new administration is “ending illegal discrimination and restoring merit-based opportunity,” U.S. President Donald Trump recently issued controversial executive orders banning diversity, equity and inclusion policies and hiring at the federal level in America. But in Canada, the most recent demographic statistics on federal judicial appointments and the professional competence and character assessments made by the Trudeau government’s non-partisan judicial advisory committees (JACs) indicate that diversity has gone hand in hand with “merit.”
-
February 25, 2025
Alberta pledges action on regulatory governance, car insurance as spring legislative session begins
The Alberta government says it plans to table 20 pieces of legislation during the provincial legislature’s upcoming spring session, dealing with issues ranging from cost-of-living concerns to professional regulation to changes in automobile insurance.
-
February 25, 2025
ACCIDENT AND SICKNESS INSURANCE - Benefits - Exclusions - Pre-existing conditions - Statutory conditions
Appeal and judicial review application by Appellant from the decision and reconsideration decision of Respondent Licence Appeal Tribunal ("Tribunal") regarding his entitlement to no-fault accident benefits from Respondent TD Insurance Company ("TD").
-
February 21, 2025
Federal Court orders reassessment of glyphosate-based pesticide over new risk evidence
The Federal Court has ordered the Pest Management Regulatory Agency (PMRA) to reconsider its renewal of a pesticide product registration, citing a lack of evidence that the agency reviewed scientific studies highlighting new or heightened risks from its active ingredient.